The Association for the Advancement of Medical Instrumentation (AAMI) is reporting that the Food and Drug Administration (FDA)’s Center for Devices and Radiological Health (CDRH) has released a final implementation plan that details actions the agency intends to take to improve the efficiency and review times of medical device submissions.
In an update to a plan released in June, the CDRH details what actions it will take in response to 11 recommendations made by Booz Allen Hamilton (BAH), an independent contractor, in a June 2014 report. The recommendations are the following:
• Adopt a holistic, multipronged approach to address five quality component areas to standardize process lifecycle management activities and improve consistency of reviews.
• Develop criteria and establish mechanisms to improve consistency in decision making throughout the review process.
• Optimize the refuse-to-accept process by improving awareness of and clarity around the administrative requirements for 510(k) submissions.
• Perform a retrospective root cause analysis of withdrawn submissions and develop a mechanism to minimize their occurrence.
• Implement a consistent practice for communicating early and frequently with sponsors during the substantive review phase to address and resolve potential issues prior to substantive interaction.
• Provide mandatory full-staff training for the three primary information technology systems that support Medical Device User Fee Amendments of 2012 (MDUFA III) reviews.
• Provide increased clarity to applicants beyond existing eCopy guidance to enhance organized submission structure.
• Evaluate tools for providing a comprehensive view of staff workload.
• Identify metrics and incorporate methods to better assess review process training satisfaction, learning, and staff behavior changes.
• Promote informal training and knowledge sharing by seasoned staff for review staff and management to share division- or science-specific review processes, lessons learned, and best practices.
• Develop CDRH-wide staff transition and succession plans to mitigate the impact of turnover on submission reviews.
To read further from AAMI, CLICK HERE.
Source: AAMI
The Sterile Processing Conference Survival Guide: How to Make the Most of Your Next Event
March 25th 2025From expert speakers to cutting-edge tools, sterile processing conferences, like the 2025 HSPA Annual Conference and the SoCal SPA's Spring Conference, offer unmatched opportunities to grow your skills, expand your network, and strengthen your department's infection prevention game.
Redefining Material Compatibility in Sterilization: Insights From AAMI TIR17:2024
March 24th 2025AAMI TIR17:2024 provides updated, evidence-based guidance on material compatibility with sterilization modalities. It offers essential insights for medical device design and ensures safety without compromising functionality.